Stay updated on Cardiol Therapeutics Press Releases
Sign up to get notified when there's something new on the Cardiol Therapeutics Press Releases page.

Latest updates to the Cardiol Therapeutics Press Releases page
- Check3 days agoChange DetectedA new press release entry Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis dated January 13, 2026 was added to the Press Releases page. Stock price figures were updated from $1.00 and $1.42 to $0.9599 and $1.34, and the older AGM press release was removed.SummaryDifference1%

- Check10 days agoChange DetectedDifference0.7%

- Check18 days agoChange DetectedThe stock price widget on the Press Releases page updated, replacing the previous values of $1.01 and $1.40 with $0.9551 and $1.33.SummaryDifference0.5%

- Check25 days agoChange DetectedThe left sidebar stock price updated to $1.01 NASDAQ:CRDL, and the previous $1.03 entry has been removed. This reflects updated pricing data for Cardiol Therapeutics on the investor information page.SummaryDifference0.2%

- Check32 days agoChange DetectedStock price values in the investor widget updated to $1.03 (NASDAQ) and $1.40 (TSX); footer copyright year updated from 2025 to 2026.SummaryDifference0.7%

- Check39 days agoChange DetectedStock pricing data in the header was updated: NASDAQ price is now $1.0001 as of December 1, 2025 and TSX price is $1.39, replacing $0.9401 and $1.30 on November 29, 2025.SummaryDifference0.7%

Stay in the know with updates to Cardiol Therapeutics Press Releases
Enter your email address, and we'll notify you when there's something new on the Cardiol Therapeutics Press Releases page.